LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

Home・Akcijų sąrašas・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

28.24 -0.18

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

27.68

Max

28.84

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-187M -136M
Pardavimai	4.3M 244M
P/E Sektoriaus vid.	9.117 66.845
Pelnas, tenkantis vienai akcijai	1.08
Pelno marža	-55.871
Darbuotojai	293
EBITDA	-22M 52M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+45.91% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-05

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	117M 1.7B
Ankstesnė atidarymo kaina	28.42
Ankstesnė uždarymo kaina	28.24

Naujienos nuotaikos

By Acuity

38%

62%

124 / 351 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

29.8 / N/A Palaikymas ir pasipriešinimas

Harmony Biosciences Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-04 23:39; UTC

Karštos akcijos

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

2026-03-04 23:20; UTC

Uždarbis

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

2026-03-04 21:43; UTC

Uždarbis

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

2026-03-04 23:48; UTC

Rinkos pokalbiai

Nikkei May Rise After Recent Selloffs -- Market Talk

2026-03-04 23:33; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

2026-03-04 23:24; UTC

Rinkos pokalbiai

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

2026-03-04 22:30; UTC

Uždarbis

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

2026-03-04 22:13; UTC

Uždarbis

Vermilion Energy 4Q EPS C$2.86 >VET

2026-03-04 22:04; UTC

Rinkos pokalbiai

RBA Slipping Behind The Curve On Rates -- Market Talk

2026-03-04 21:53; UTC

Uždarbis

Lithium Americas 4Q Rev $66.8M >LAC

2026-03-04 21:53; UTC

Uždarbis

Lithium Americas 4Q Loss/Shr 52c >LAC

2026-03-04 21:52; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:50; UTC

Uždarbis

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

2026-03-04 21:50; UTC

Rinkos pokalbiai

Tech, Media & Telecom Roundup: Market Talk

2026-03-04 21:48; UTC

Uždarbis

Webull 4Q Rev $165.2M >BULL

2026-03-04 21:48; UTC

Uždarbis

Webull 4Q EPS 1c >BULL

2026-03-04 21:45; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-03-04 21:45; UTC

Rinkos pokalbiai

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

2026-03-04 21:40; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:36; UTC

Svarbiausios naujienos

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

2026-03-04 21:27; UTC

Uždarbis

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

2026-03-04 21:17; UTC

Rinkos pokalbiai

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

2026-03-04 21:16; UTC

Uždarbis

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q EPS $1.50 >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q Net $7.35B >AVGO

2026-03-04 21:15; UTC

Uždarbis

Broadcom 1Q Rev $19.31B >AVGO

Akcijų palyginimas

Kainos pokytis

Harmony Biosciences Holdings Inc Prognozė

Kainos tikslas

By TipRanks

45.91% į viršų

12 mėnesių prognozė

Vidutinis 41.25 USD 45.91%

Aukščiausias 62 USD

Žemiausias 25 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Harmony Biosciences Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

8 ratings

Pirkti

Laikyti

Parduoti

Remiantis 8 analitikų, pateikusių Harmony Biosciences Holdings Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

29.8 / N/APalaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

124 / 351 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.